# Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

> **NCT02307396** · PHASE4 · COMPLETED · sponsor: **Technical University of Munich** · enrollment: 21 (actual)

## Conditions studied

- Schizophrenia
- Schizophrenia and Disorders With Psychotic Features
- Schizoaffective Disorders

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Amisulpride
- **DRUG:** Risperidone
- **DRUG:** Haloperidol
- **DRUG:** Quetiapine
- **DRUG:** Perphenazine
- **DRUG:** Sulpiride
- **DRUG:** bromperidol
- **DRUG:** Zuclopenthixol
- **DRUG:** Thioridazine
- **DRUG:** Paliperidone
- **DRUG:** Ziprasidone
- **DRUG:** Benperidol
- **DRUG:** Fluspirilene
- **DRUG:** Pimozide
- **DRUG:** Perazine
- **DRUG:** Fluphenazine
- **DRUG:** Flupentixole
- **DRUG:** Sertindole

## Key facts

- **NCT ID:** NCT02307396
- **Lead sponsor:** Technical University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-01
- **Primary completion:** 2016-06-22
- **Final completion:** 2016-06-22
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307396, "Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02307396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*